The BRAF V600E gene mutation occurs in about 55% of melanomas. The fact that there are targeted therapies to address that mutation is hopeful. Unfortunately, the first generation BRAF-inhibitors showed quick and early…
At the time, the site was hosted by Spacestar Communications (now defunct). Now, it's hosted by Cyrus One. I wonder who maintains it.
The BRAF V600E gene mutation occurs in about 55% of melanomas. The fact that there are targeted therapies to address that mutation is hopeful. Unfortunately, the first generation BRAF-inhibitors showed quick and early…
At the time, the site was hosted by Spacestar Communications (now defunct). Now, it's hosted by Cyrus One. I wonder who maintains it.